ChipCare Corp has closed a $5-million series A financing to bring its handheld, blood-testing platform for HIV and other infectious and non-communicable diseases to market. Financing for the Univ of Toronto start-up was led by Puffin Partners LP, Dallas TX, and includes MaRS Innovation, Maple Leaf Angels, Winfield Venture Group, Epic Capital and US and Canadian angel investors. ChipCare's HIV-related test is the first product it has commercialized, targeted at linking HIV patients to appropriate treatments. It is particularly useful for treating patients in remote settings....
Other stories mentioning these organizations, people and topics
| Organizations: | ChipCare Corp, Epic Capital, Maple Leaf Angels, MaRS Innovation, Puffin Partners LP, Univ of Toronto, and Winfield Venture Group |
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.